Bitcoin Fuels Peptide Market as Unregulated Sales Surge

The peptide market has seen significant growth in recent times, with gray-market vendors receiving $32 million in cryptocurrency during the first quarter of 2026. This figure represents a 700% increase from the same period last year and puts the sector on pace to exceed $100 million annually.

One reason for this growth is that banks and card networks often reject merchants selling unapproved compounds, leaving them with no choice but to accept cryptocurrency payments. Bitcoin has become a popular choice among these vendors, attracting first-time crypto buyers who are drawn in by the promise of anonymity and ease of use.

Zach, a 49-year-old marketing director, is one such buyer who recently purchased 20 vials of retatrutide from a Chinese seller for $240. The experimental weight-loss peptide is being developed by Eli Lilly & Co., but the vendor required Bitcoin payment due to bank restrictions.

Experts warn that many products sold in this market lack reliable human safety and effectiveness data, making it a Wild West of sorts. Lee Rosebush, chair of the American Academy of Peptide Medicine, says clearer rules could reduce research-only suppliers while improving access to tested medicines.